TrialCardiovascular diabetology2017

Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.

Malgorzata Poreba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.